[1] |
ADELOYE D, CHUA S, LEE C,et al. Global and regional estimates of COPD prevalence:systematic review and meta-analysis[J]. J Glob Health, 2015, 5(2):020415. DOI: 10.7189/jogh.05.020415.
|
[2] |
WANG C, XU J Y, YANG L,et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study):a national cross-sectional study[J]. Lancet, 2018, 391(10131):1706-1717. DOI: 10.1016/S0140-6736(18)30841-9.
|
[3] |
Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease 2022 report[EB/OL].(2021-11-15)[2022-04-18].
|
[4] |
PAUWELS R, BUIST A, CALVERLEY P,et al. Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary[J]. American Journal of Respiratory and Critical Care Medicine, 2001, 163(5):1256-1276. DOI: 10.1164/AJRCCM.163.5.2101039.
|
[5] |
|
[6] |
LU H H, ZENG H H, CHEN Y. Early chronic obstructive pulmonary disease:a new perspective[J]. Chronic Dis Transl Med, 2021, 7(2):79-87. DOI: 10.1016/j.cdtm.2021.02.003.
|
[7] |
WAN E S, HOKANSON J E, MURPHY J R,et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study[J]. Am J Respir Crit Care Med, 2011, 184(1):57-63. DOI: 10.1164/rccm.201101-0021OC.
|
[8] |
KHAN R M M, CHUA Z J Y, TAN J C,et al. From pre-diabetes to diabetes:diagnosis,treatments and translational research[J]. Medicina (Kaunas), 2019, 55(9):546. DOI: 10.3390/medicina55090546.
|
[9] |
NIIRANEN T J, LARSON M G, MCCABE E L,et al. Prognosis of prehypertension without progression to hypertension[J]. Circulation, 2017, 136(13):1262-1264. DOI: 10.1161/CIRCULATIONAHA.117.029317.
|
[10] |
HAN M K, AGUSTI A, CELLI B R,et al. From GOLD 0 to pre-COPD[J]. Am J Respir Crit Care Med, 2021, 203(4):414-423. DOI: 10.1164/rccm.202008-3328PP.
|
[11] |
MARTINEZ F J, AGUSTI A, CELLI B R,et al. Treatment trials in young patients with chronic obstructive pulmonary disease and pre-chronic obstructive pulmonary disease patients:time to move forward[J]. Am J Respir Crit Care Med, 2022, 205(3):275-287. DOI: 10.1164/rccm.202107-1663SO.
|
[12] |
LAUCHO-CONTRERAS M E, COHEN-TODD M. Early diagnosis of COPD:myth or a true perspective[J]. Eur Respir Rev, 2020, 29(158):200131. DOI: 10.1183/16000617.0131-2020.
|
[13] |
SCADDING J G. Health and disease:what can medicine do for philosophy? [J]. J Med Ethics, 1988, 14(3):118-124. DOI: 10.1136/jme.14.3.118.
|
[14] |
CHEN J H, WELDEMICHAEL L, ZENG S Y,et al. Actigraphy informs distinct patient-centered outcomes in Pre-COPD[J]. Respir Med, 2021, 187:106543. DOI: 10.1016/j.rmed.2021.106543.
|
[15] |
JIN J. Screening for chronic obstructive pulmonary disease[J]. JAMA, 2022, 327(18):1831. DOI: 10.1001/jama.2022.6110.
|
[16] |
TANG L Y W, COXSON H O, LAM S,et al. Towards large-scale case-finding:training and validation of residual networks for detection of chronic obstructive pulmonary disease using low-dose CT[J]. Lancet Digit Health, 2020, 2(5):e259-267. DOI: 10.1016/S2589-7500(20)30064-9.
|
[17] |
POLVERINO F, HYSINGER E B, GUPTA N,et al. Lung MRI as a potential complementary diagnostic tool for early COPD[J]. Am J Med, 2020, 133(6):757-760. DOI: 10.1016/j.amjmed.2019.12.009.
|
[18] |
HARVEY B G, STRULOVICI-BAREL Y, KANER R J,et al. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity[J]. Eur Respir J, 2015, 46(6):1589-1597. DOI: 10.1183/13993003.02377-2014.
|
[19] |
YSERBYT J, DOOMS C, JANSSENS W,et al. Endoscopic advanced imaging of the respiratory tract:exploring probe-based confocal laser endomicroscopy in emphysema[J]. Thorax, 2018, 73(2):188-190. DOI: 10.1136/thoraxjnl-2016-209746.
|
[20] |
DI MARCO F, BALBO P, DE BLASIO F,et al. Early management of COPD:where are we now and where do we go from here? A Delphi consensus project[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14:353-360. DOI: 10.2147/COPD.S176662.
|
[21] |
DIAB N, GERSHON A S, SIN D D,et al. Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2018, 198(9):1130-1139. DOI: 10.1164/rccm.201804-0621CI.
|
[22] |
HO T, CUSACK R P, CHAUDHARY N,et al. Under- and over-diagnosis of COPD:a global perspective[J]. Breathe (Sheff), 2019, 15(1):24-35. DOI: 10.1183/20734735.0346-2018.
|
[23] |
RAY E, CULLIFORD D, KRUK H,et al. Specialist respiratory outreach:a case-finding initiative for identifying undiagnosed COPD in primary care[J]. NPJ Prim Care Respir Med, 2021, 31(1):7. DOI: 10.1038/s41533-021-00219-x.
|
[24] |
PRETEROTI M, WHITMORE G A, VANDEMHEEN K L,et al. Population-based case-finding to identify subjects with undiagnosed asthma or COPD[J]. Eur Respir J, 2020, 55(6):2000024. DOI: 10.1183/13993003.00024-2020.
|
[25] |
SEKINE Y, YANAGIBORI R, SUZUKI K,et al. Surveillance of chronic obstructive pulmonary disease in high-risk individuals by using regional lung cancer mass screening[J]. Int J Chron Obstruct Pulmon Dis, 2014, 9:647-656. DOI: 10.2147/COPD.S62053.
|
[26] |
ULRIK C S, LØKKE A, DAHL R,et al. Early detection of COPD in general practice[J]. Int J Chron Obstruct Pulmon Dis, 2011, 6:123-127. DOI: 10.2147/COPD.S16929.
|
[27] |
GUIRGUIS-BLAKE J M, SENGER C A, WEBBER E M,et al. Screening for chronic obstructive pulmonary disease:evidence report and systematic review for the US preventive services task force[J]. JAMA, 2016, 315(13):1378-1393. DOI: 10.1001/jama.2016.2654.
|
[28] |
FLETCHER C, PETO R. The natural history of chronic airflow obstruction[J]. Br Med J, 1977, 1(6077):1645-1648. DOI: 10.1136/bmj.1.6077.1645.
|
[29] |
|
[30] |
|
[31] |
WELTE T, VOGELMEIER C, PAPI A. COPD:early diagnosis and treatment to slow disease progression[J]. Int J Clin Pract, 2015, 69(3):336-349. DOI: 10.1111/ijcp.12522.
|
[32] |
SUN Y L, ZHOU J Y. New insights into early intervention of chronic obstructive pulmonary disease with mild airflow limitation[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14:1119-1125. DOI: 10.2147/COPD.S205382.
|
[33] |
MARTINEZ F J, HAN M K, ALLINSON J P,et al. At the root:defining and halting progression of early chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2018, 197(12):1540-1551. DOI: 10.1164/rccm.201710-2028PP.
|
[34] |
BAI J W, CHEN X X, LIU S S,et al. Smoking cessation affects the natural history of COPD[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12:3323-3328. DOI: 10.2147/COPD.S150243.
|
[35] |
SCANLON P D, CONNETT J E, WALLER L A,et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study[J]. Am J Respir Crit Care Med, 2000, 161(2 Pt 1):381-390. DOI: 10.1164/ajrccm.161.2.9901044.
|
[36] |
|
[37] |
BURKES R M, DRUMMOND M B. Initiating drug therapy in early stage chronic obstructive pulmonary disease:does it impact the course and outcome? [J]. Curr Opin Pulm Med, 2019, 25(2):132-137. DOI: 10.1097/MCP.0000000000000553.
|
[38] |
CORHAY J L,LOUIS R. The UPLIFT study (understanding potential long-term impacts on function with tiotropium)[J]. Rev Med Liege,2009,64(1):52-57.
|
[39] |
CORHAY J L,LOUIS R. Clinical study of the month:the TORCH study (towards a Revolution in COPD Health)[J]. Rev Med Liege,2007,62(4):230-234.
|
[40] |
LI C L, ZHOU Y M, LIU S,et al. Tiotropium discontinuation in patients with early-stage COPD:a prospective observational cohort study[J]. ERJ Open Res, 2019, 5(1):00175-02018. DOI: 10.1183/23120541.00175-02018.
|
[41] |
JÁCOME C, MARQUES A. Pulmonary rehabilitation for mild COPD:a systematic review[J]. Respir Care, 2014, 59(4):588-594. DOI: 10.4187/respcare.02742.
|
[42] |
SAHIN H, NAZ I. The effect of pulmonary rehabilitation on smoking and health outcomes in COPD patients[J]. Clin Respir J, 2021, 15(8):855-862. DOI: 10.1111/crj.13373.
|
[43] |
ANEES UR REHMAN, AHMAD HASSALI M A, MUHAMMAD S A,et al. The economic burden of chronic obstructive pulmonary disease (COPD) in the USA,Europe,and Asia:results from a systematic review of the literature[J]. Expert Rev Pharmacoecon Outcomes Res, 2020, 20(6):661-672. DOI: 10.1080/14737167.2020.1678385.
|
[44] |
|
[45] |
MENN P, HEINRICH J, HUBER R M,et al. Direct medical costs of COPD—an excess cost approach based on two population-based studies[J]. Respir Med, 2012, 106(4):540-548. DOI: 10.1016/j.rmed.2011.10.013.
|
[46] |
SORIANO J B, ANCOCHEA J, CELLI B R. The most beautiful COPD chart in the world:all together to end COPD![J]. Eur Respir J, 2019, 54(6):1902047. DOI: 10.1183/13993003.02047-2019.
|
[47] |
AGUSTI A, ZHANG J. Chronic obstructive pulmonary disease at the beginning of the XXI Century[J]. J Thorac Dis, 2019, 11(11):E210-213. DOI: 10.21037/jtd.2019.10.50.
|
[48] |
|